(ANSA) - LONDON, 29 JAN - The AstraZeneca / Oxford anti-Covid vaccine maintains its effectiveness even with an interval of "three months" between first dose and booster, according to the strategy chosen by the United Kingdom. This was stated by managing director Pascal Soriot in a briefing with other managers of the company and with Professor Andrew Pollard, from Oxford, underlining the "flexibility" of use and the ease of storage and administration of a vaccine developed in just 9 months despite the difficulties. . "We have great confidence in this vaccine and its potential for use", Pollard said, saying he was "encouraged" by the results achieved.
(HANDLE).
